Formula: | C15H13F6N3O4S2 |
Molecular Weight: | 477.41 |
Rotatable Bond Donors: | 5 |
clogP: | 3.52 |
Topological Polar Surface Area: | 108.39 |
Lipinski's RO5: | MW: 477.41 HBA: 7 HBD: 3 RB: 5 LogP: 3.52 |
Rule of Three: | MW: 477.41 HBA: 7 HBD: 3 RB: 5 LogP: 3.52 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC68268147 | 1.0 | ZINC68268147 RDKit 3D 30 31 0 0 0 0 0 0 0 0999 V2000 6.1497 4.2401 0.5603 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5659 3.0760 -0.1788 C 0 0 0 0 0 0 0 0 0 0 0 0 5.6773 2.9766 -1.3937 O 0 0 0 0 0 0 0 0 0 0 0 0 4.9347 2.2359 0.7111 N 0 0 0 0 0 0 0 0 0 0 0 0 4.3437 1.0661 0.3109 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2816 0.5194 -0.8778 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5951 -0.6798 -0.8048 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4306 -1.4735 -2.0421 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1238 -1.0064 0.4514 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1979 -2.3720 1.0830 S 0 0 0 0 0 0 0 0 0 0 0 0 3.1091 -3.0217 2.0034 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7073 -3.0634 -0.0933 O 0 0 0 0 0 0 0 0 0 0 0 0 0.8776 -1.7505 1.9672 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.2298 -1.1949 1.2512 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0842 -0.4933 0.0576 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1846 0.1283 -0.5297 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4436 0.0998 0.0833 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6410 0.7655 -0.5877 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1788 2.0096 -1.1438 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.2145 -0.1004 -1.6941 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6661 -1.2887 -1.2300 F 0 0 0 0 0 0 0 0 0 0 0 0 -5.2413 0.4924 -2.3424 F 0 0 0 0 0 0 0 0 0 0 0 0 -3.2796 -0.3864 -2.6357 F 0 0 0 0 0 0 0 0 0 0 0 0 -4.8064 1.0681 0.3389 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7899 1.7634 -0.2763 F 0 0 0 0 0 0 0 0 0 0 0 0 -4.4074 1.8245 1.3943 F 0 0 0 0 0 0 0 0 0 0 0 0 -5.3722 -0.0469 0.8535 F 0 0 0 0 0 0 0 0 0 0 0 0 -2.5648 -0.5783 1.3001 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4662 -1.2020 1.8904 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5760 0.2097 1.5735 S 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 2 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 1 0 7 9 2 0 9 10 1 0 10 11 2 0 10 12 2 0 10 13 1 0 13 14 1 0 14 15 2 0 15 16 1 0 16 17 2 0 17 18 1 0 18 19 1 0 18 20 1 0 20 21 1 0 20 22 1 0 20 23 1 0 18 24 1 0 24 25 1 0 24 26 1 0 24 27 1 0 17 28 1 0 28 29 2 0 9 30 1 0 30 5 1 0 29 14 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |